The treatment of the hospitalized patient with sepsis remains a clinical conundrum, due in large part to the complexity of the host response to infection and tissue injury. Pro- and antiinflammatory cytokines play critical roles in the development of sepsis syndromes, but their production is often localized to individual tissues, rather than the systemic circulation. Current therapeutic approaches for the treatment of sepsis syndromes involve the systemic administration of biological response modifiers, such as cytokine antagonists or antiinflammatory agents. To date, none of these agents has proven effective, and one explanation may be that their systemic administration is an inefficient or even inappropriate means to treat a more localized inflammatory or immunosuppressive response. We have proposed that he targeted delivery of protein-based therapies using a recombinant adenoviral vector can directly modulate the inflammatory or apoptotic processes occurring in the target tissue, without systemic immune suppression or activation. Therefore, the overall objective of these studies is to determine the feasibility of adenovirus gene transfer as a herapeutic modality. More specifically, the goals of this proposal are to determine whether the forced overexpression of initially IL-10, but also in later years, a dominant negative I-KB super-repressor, will blunt the sepsis responses in arget organs without producing systemic immune suppression. The two specific aims of the current application are: 1) To determine whether targeted expression of IL- 10 in the lungs of mice with an adenoviral vector can prevent the development of respiratory distress syndrome in a zymosan-induced model of multisystem organ failure, without increased expression in other organs or the induction of T-cell hyporesponsiveness and immune suppression, and 2) To determine the mechanisms by which targeted expression of IL- 10 in the thymus of mice can reduce caspase-3 iependent thymocyte apoptosis and improve outcome in a cecal ligation and puncture model of a compensatory mtiinflammatory response syndrome. The studies proposed in this application will ultimately determine the utility and safety ofadenovirus based gene therapy as a means of targeting protein-based therapies to individual tissues and organs in sepsis syndromes.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project (R01)
Project #
Application #
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Program Officer
Somers, Scott D
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Florida
Schools of Medicine
United States
Zip Code
Cuenca, Alex G; Delano, Matthew J; Kelly-Scumpia, Kindra M et al. (2010) Cecal ligation and puncture. Curr Protoc Immunol Chapter 19:Unit 19.13
Efron, Philip A; Matsumoto, Tadashi; McAuliffe, Priscilla F et al. (2009) Major hepatectomy induces phenotypic changes in circulating dendritic cells and monocytes. J Clin Immunol 29:568-81
Tschoeke, S K; Oberholzer, C; LaFace, D et al. (2008) Endogenous IL-10 regulates sepsis-induced thymic apoptosis and improves survival in septic IL-10 null mice. Scand J Immunol 68:565-71
Matsumoto, Tadashi; O'Malley, Kerri; Efron, Philip A et al. (2006) Interleukin-6 and STAT3 protect the liver from hepatic ischemia and reperfusion injury during ischemic preconditioning. Surgery 140:793-802
Matsumoto, Tadashi; Efron, Philip A; Tsujimoto, Hironori et al. (2005) Splenic transposition is superior to caudal shunt as a model of murine total hepatic ischemia. Lab Invest 85:90-8
Tsujimoto, Hironori; Ono, Satoshi; Majima, Takashi et al. (2005) Neutrophil elastase, MIP-2, and TLR-4 expression during human and experimental sepsis. Shock 23:39-44
Scumpia, Philip O; Moldawer, Lyle L (2005) Biology of interleukin-10 and its regulatory roles in sepsis syndromes. Crit Care Med 33:S468-71
Efron, Philip A; Tsujimoto, Hironori; Bahjat, Frances R et al. (2005) Differential maturation of murine bone-marrow derived dendritic cells with lipopolysaccharide and tumor necrosis factor-alpha. J Endotoxin Res 11:145-60
Oberholzer, Andreas; Oberholzer, Caroline; Efron, Philip A et al. (2005) Functional modification of dendritic cells with recombinant adenovirus encoding interleukin 10 for the treatment of sepsis. Shock 23:507-15
Tsujimoto, Hironori; Uchida, Takefumi; Efron, Philip A et al. (2005) Flagellin enhances NK cell proliferation and activation directly and through dendritic cell-NK cell interactions. J Leukoc Biol 78:888-97

Showing the most recent 10 out of 13 publications